General Information of Drug (ID: DM70BU5)

Drug Name
Thalidomide Drug Info
Synonyms
Algosediv; Asmadion; Asmaval; Bonbrain; Bonbrrin; Calmore; Calmorex; Contergan; Corronarobetin; Distaval; Distaxal; Distoval; Ectiluran; Enterosediv; Gastrinide; Glupan; Glutanon; Grippex; Hippuzon; Imidene; Isomin; Kedavon; Kevadon; Neaufatin; Neosedyn; Neosydyn; Nerosedyn; Neufatin; Neurodyn; Neurosedin; Neurosedym; Neurosedyn; Nevrodyn; Nibrol; Noctosediv; Noxodyn; Pangul; Pantosediv; Polygripan; Profarmil; Psycholiquid; Psychotablets; Quetimid; Quietoplex; Sandormin; Sedalis; Sedimide; Sedin; Sedisperil; Sedoval; Shinnibrol; Sleepan; Slipro; Softenil; Softenon; Synovir; Talargan; Talidomida; Talidomide; Talimol; Talismol; Talizer; Telagan; Telargan; Telargean; Tensival; Thaled; Thalidomidum; Thalin; Thalinette; Thalomid; Thalomide; Theophilcholine; Valgis; Valgraine; Yodomin; Celgene Brand of Thalidomide; Talidomide [DCIT]; Thalidomide Celgene; Thalidomide Pharmion; Asidon 3; ENMD 0995; IN1061; Thalidomine USP26; Alpha-Phthalimidoglutarimide; E-217; Imida-lab; Imidan (peyta); N-Phthalimidoglutamic acid imide; N-Phthaloylglutamimide; N-Phthalylglutamic acid imide; Poly-Giron; Predni-Sediv; Pro-Bam M; Pro-ban M; Sedalis sedi-lab; Shin-naito S; THALIDOMIDE (AIDS INITIATIVE); Talidomida [INN-Spanish]; Thaled (TN); Thalidomide (soluble form); Thalidomidum [INN-Latin]; Thalomid (TM); Thalomid (TN); Thalomid, Thalidomide; Alpha-N-Phthalylglutaramide; Thalidomide [USAN:INN:BAN]; Alpha-(N-Phthalimido)glutarimide; N-Phthalyl-glutaminsaeure-imid; N-Phthalyl-glutaminsaeure-imid [German]; Thalidomide (+ and-); Thalidomide (JAN/USP/INN); N-(2,6-Dioxo-3-piperidyl)phthalimide; (+)-Thalidomide; (+-)-Thalidomide; (+/-)-THALIDOMIDE; (inverted question mark)-Thalidomide; 2,6-Dioxo-3-phthalimidopiperidine; 3-Phthalimidoglutarimide
Indication
Disease Entry ICD 11 Status REF
Adult T-cell leukemia/lymphoma Approved [1]
Advanced cancer 2A00-2F9Z Approved [1]
Complex regional pain syndrome type 1 Approved [1]
Hepatosplenic T-cell lymphoma Approved [1]
Large granular lymphocytic leukemia 2A90.1 Approved [1]
Leukemia Approved [1]
MALT lymphoma Approved [1]
Multiple myeloma 2A83 Approved [2]
Nodal marginal zone lymphoma 2A85.0 Approved [1]
Pain MG30-MG3Z Approved [1]
Plasma cell myeloma 2A83.1 Approved [1]
Primary cutaneous peripheral T-cell lymphoma not otherwise specified Approved [1]
Prolymphocytic leukaemia 2A82.1 Approved [1]
Recurrent adult burkitt lymphoma 2A85.6 Approved [1]
Small intestine lymphoma Approved [1]
Splenic marginal zone lymphoma Approved [1]
Testicular lymphoma Approved [1]
Urinary bladder neoplasm Approved [1]
Waldenstrom macroglobulinemia 2A85.4 Approved [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [3]
Colon cancer 2B90.Z Investigative [1]
Therapeutic Class
Immunosuppressive Agents
Cross-matching ID
PubChem CID
5426
ChEBI ID
CHEBI:74947
CAS Number
CAS 50-35-1
TTD Drug ID
DM70BU5
VARIDT Drug ID
DR00461
INTEDE Drug ID
DR1572
ACDINA Drug ID
D00669

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Patented Agent(s)
Drug(s) Targeting Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nafamostat DMU1XOD Pancreatitis DC31-DC34 Approved [20]
Pentoxifylline DMU3DNC Alcoholic hepatitis DB94.1 Approved [21]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [22]
Enbrel DM7RNP3 Arthritis FA20 Approved [23]
Golimumab DMHZV7X Psoriatic arthritis FA21 Approved [24]
Certolizumab DM5CL9Z Rheumatoid arthritis FA20 Approved [25]
Etanercept DMCV109 Arthritis FA20 Approved [26]
Adalimumab DMQMV1B Crohn disease DD70 Approved [27]
Infliximab DMH7OIA Crohn disease DD70 Approved [28]
Golnerminogene pradenovac DMKWV4B Esophageal cancer 2B70 Phase 3 [29]
Indomethacin DMSC4A7 Bursitis Approved [194]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [195]
Fructose DM43AN2 Vomiting MD90 Approved [112]
Ketoprofen DMRKXPT Bursitis Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [196]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [197]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [198]
Gefitinib DM15F0X Colon adenocarcinoma Approved [199]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [200]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2A6 (CYP2A6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [30]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [31]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [33]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [31]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [34]
Metronidazole DMTIVEN Abscess Approved [35]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [36]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [37]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [31]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A5 (CYP3A5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [38]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [39]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [40]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [41]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [42]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [43]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [44]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [45]
Verapamil DMA7PEW Angina pectoris BA40 Approved [46]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [41]
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [88]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [90]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [90]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [91]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [92]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [95]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [96]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2E1 (CYP2E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Folic Acid DMEMBJC Colorectal carcinoma Approved [47]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [48]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [32]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [49]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [50]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [51]
Verapamil DMA7PEW Angina pectoris BA40 Approved [31]
Estrone DM5T6US Acne vulgaris ED80 Approved [52]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [53]
Ethanol DMDRQZU Chronic pain MG30 Approved [54]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C18 (CYP2C18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [31]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [55]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [36]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [56]
Diazepam DM08E9O Alcohol withdrawal Approved [57]
Methadone DMTW6IU Advanced cancer 2A00-2F9Z Approved [58]
Dapsone DM4LT8A Acne vulgaris ED80 Approved [59]
Lidocaine DML4ZOT Anaesthesia 9A78.6 Approved [31]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [60]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C8 (CYP2C8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [30]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [61]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [61]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [31]
Verapamil DMA7PEW Angina pectoris BA40 Approved [62]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [63]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [64]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [61]
Mycophenolate mofetil DMPQAGE Hepatosplenic T-cell lymphoma Approved [65]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [36]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C9 (CYP2C9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [66]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [67]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [68]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [31]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [69]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [31]
Verapamil DMA7PEW Angina pectoris BA40 Approved [70]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [71]
Estrone DM5T6US Acne vulgaris ED80 Approved [72]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [73]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2B6 (CYP2B6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [74]
Verapamil DMA7PEW Angina pectoris BA40 Approved [31]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [75]
Estrone DM5T6US Acne vulgaris ED80 Approved [68]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [76]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [77]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [78]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [79]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [80]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [81]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [97]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [98]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [99]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [100]
Clopidogrel DMOL54H Acute coronary syndrome BA41 Approved [101]
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [102]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [103]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [104]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [105]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [106]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Mephenytoin 4-hydroxylase (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [82]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [66]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [83]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [84]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [31]
Verapamil DMA7PEW Angina pectoris BA40 Approved [85]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [55]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [73]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [86]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [36]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [5]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [87]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [5]
Diazepam DM08E9O Alcohol withdrawal Approved [5]
Dapsone DM4LT8A Acne vulgaris ED80 Approved [5]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [5]
Nateglinide DMLK2QH Diabetic complication 5A2Y Approved [5]
Ketobemidone DMM3L6Z Pain MG30-MG3Z Approved [5]
Irbesartan DMTP1DC Diabetic kidney disease GB61.Z Approved [5]
Terbinafine DMI6HUW Fungal infection 1F29-1F2F Approved [5]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2C19 (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [107]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [108]
Chloramphenicol DMFXEWT Bacterial infection 1A00-1C4Z Approved [97]
Capsaicin DMGMF6V Back pain ME84.Z Approved [109]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [110]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [111]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [110]
Desipramine DMT2FDC Attention deficit hyperactivity disorder 6A05.Z Approved [107]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [88]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [113]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [108]
Proguanil DMBL79I Malaria 1F40-1F45 Approved [110]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [110]
Loratadine DMF3AN7 Allergy 4A80-4A85 Approved [114]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [90]
Capsaicin DMGMF6V Back pain ME84.Z Approved [115]
Axitinib DMGVH6N Renal cell carcinoma 2C90 Approved [116]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [117]
Vidarabine DM0N85H Hepatosplenic T-cell lymphoma Approved [117]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [118]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [119]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [120]
Etidronic acid DM1XHYJ Bone Paget disease Approved [117]
Tiaprofenic acid DM23D7J Osteoarthritis FA00-FA05 Approved [117]
Bromperidol DM24XYQ Schizophrenia 6A20 Approved [117]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [121]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [125]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [126]
Vismodegib DM5IXKQ Basal cell carcinoma 2C32 Approved [127]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [128]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [129]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [130]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Cantharidin DMBP5N3 Molluscum contagiosum infection 1E76 Approved [131]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [134]
Menthol DMG2KW7 Back pain ME84.Z Approved [135]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Arsenic DMTL2Y1 N. A. N. A. Approved [137]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [138]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [139]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [140]
Urethane DM7NSI0 N. A. N. A. Phase 4 [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [142]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [143]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [145]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [146]
Selenium DM25CGV N. A. N. A. Approved [147]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [142]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [148]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [148]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Angiopoietin-2 (ANGPT2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Methotrexate DM2TEOL Anterior urethra cancer Approved [151]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Propranolol DM79NTF Angina pectoris BA40 Approved [155]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [157]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [158]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [159]
Methotrexate DM2TEOL Anterior urethra cancer Approved [160]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [161]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [162]
Quercetin DM3NC4M Obesity 5B81 Approved [163]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [164]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [165]
Ethacrynic acid DM60QMR Edema MG29 Approved [166]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kalirin (KALRN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [168]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Arsenic DMTL2Y1 N. A. N. A. Approved [137]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [169]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [146]
Methotrexate DM2TEOL Anterior urethra cancer Approved [173]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [125]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [174]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [176]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [179]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Metoclopramide DMFA5MY Nausea MD90 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Complement C3 (C3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [180]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [181]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [183]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [184]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [185]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [186]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [183]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein c-Fos (FOS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [187]
Verapamil DMA7PEW Angina pectoris BA40 Approved [188]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Acebutolol DM0TI4U Hypertension BA00-BA04 Approved [188]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [189]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [190]
Methotrexate DM2TEOL Anterior urethra cancer Approved [191]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [192]
Quercetin DM3NC4M Obesity 5B81 Approved [193]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interferon gamma (IFNG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [201]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [202]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [203]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [204]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [205]
Quercetin DM3NC4M Obesity 5B81 Approved [206]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [207]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [208]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [209]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-1 beta (IL1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [210]
Gefitinib DM15F0X Colon adenocarcinoma Approved [211]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [212]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [213]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [212]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [214]
Selenium DM25CGV N. A. N. A. Approved [215]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [216]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [217]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-reactive protein (CRP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lidocaine DML4ZOT Anaesthesia 9A78.6 Approved [112]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [219]
Quercetin DM3NC4M Obesity 5B81 Approved [220]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [221]
Acalabrutinib DM7GCVW leukaemia 2A60-2B33 Approved [222]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [223]
Tibolone DM78XFG Anabolic metabolism 5C50-5C8Z Approved [224]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Milrinone DM8TUPF Congestive heart failure BD10 Approved [226]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [227]
Quercetin DM3NC4M Obesity 5B81 Approved [228]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [229]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [230]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [231]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [232]
Acetylcholine DMDF79Z Cataract 9B10 Approved [233]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [234]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [235]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [236]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [237]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [238]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [239]
Paclitaxel DMLB81S Breast carcinoma Approved [240]
Floxuridine DM04LR2 Colorectal cancer 2B91.Z Approved [241]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [242]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [243]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [244]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dantrolene DM1D8XY Hyperthermia MG26 Approved [245]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [246]
Quercetin DM3NC4M Obesity 5B81 Approved [247]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [248]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Testosterone DM7HUNW Hot flushes GA30 Approved [250]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [251]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-6 (IL6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [252]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [253]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [255]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [256]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [210]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [214]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [257]
Methotrexate DM2TEOL Anterior urethra cancer Approved [252]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Jun (JUN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [258]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [259]
Fructose DM43AN2 Vomiting MD90 Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [260]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [261]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [262]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [263]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [264]
Methotrexate DM2TEOL Anterior urethra cancer Approved [265]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calbindin (CALB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [267]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [153]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [268]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [269]
Vandetanib DMRICNP Solid tumour/cancer 2A00-2F9Z Approved [270]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [271]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [180]
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [272]
Selenium DM25CGV N. A. N. A. Approved [273]
Quercetin DM3NC4M Obesity 5B81 Approved [274]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [275]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [276]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [277]
Testosterone DM7HUNW Hot flushes GA30 Approved [278]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Goserelin DMAT8CG Breast cancer 2C60-2C65 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Annexin A2 (ANXA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [280]
Quercetin DM3NC4M Obesity 5B81 Approved [281]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [282]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [283]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [284]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [285]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [286]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Sp1 (SP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fructose DM43AN2 Vomiting MD90 Approved [112]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [287]
Quercetin DM3NC4M Obesity 5B81 Approved [288]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [289]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [290]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [292]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [287]
Plicamycin DM7C8YV Hypercalcaemia 5B91.0 Approved [293]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [294]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [295]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [296]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [297]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [298]
Cepharanthine DM9Y5JB N. A. N. A. Approved [299]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [300]
Clozapine DMFC71L Schizophrenia 6A20 Approved [301]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [302]
Trifluoperazine DMKBYWI Anxiety Approved [303]
Olanzapine DMPFN6Y Bipolar depression Approved [301]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [304]
Selenium DM25CGV N. A. N. A. Approved [305]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [306]
Quercetin DM3NC4M Obesity 5B81 Approved [307]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [308]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [309]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [185]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [310]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [311]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [312]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Testosterone enanthate DMB6871 N. A. N. A. Approved [313]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [315]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [316]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 1 (PARP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Gefitinib DM15F0X Colon adenocarcinoma Approved [317]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [318]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [319]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [320]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [321]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [320]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [322]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [323]
Methotrexate DM2TEOL Anterior urethra cancer Approved [324]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [210]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [181]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [325]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [326]
Ethanol DMDRQZU Chronic pain MG30 Approved [327]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [328]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [252]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [329]
Pomalidomide DMTGBAX Plasma cell myeloma 2A83.1 Approved [330]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-8 (CXCL8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [331]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [332]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [333]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [255]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [261]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [210]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [212]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [213]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [334]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [212]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [335]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Quercetin DM3NC4M Obesity 5B81 Approved [336]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [337]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [338]
Estrone DM5T6US Acne vulgaris ED80 Approved [335]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [339]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [338]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [340]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [341]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [342]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [343]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Verapamil DMA7PEW Angina pectoris BA40 Approved [344]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [345]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [197]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [346]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [210]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [347]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [348]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [349]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [124]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [190]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [348]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [185]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [349]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [351]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [352]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Folic Acid DMEMBJC Colorectal carcinoma Approved [354]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-1 (CDH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [158]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [355]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [356]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [357]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [358]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [359]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [360]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 2 (CCL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [256]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [180]
Gefitinib DM15F0X Colon adenocarcinoma Approved [361]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [362]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [363]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [364]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [365]
Quercetin DM3NC4M Obesity 5B81 Approved [366]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [367]
Clindamycin DM15HL8 Acne vulgaris ED80 Approved [367]
Selenium DM25CGV N. A. N. A. Approved [368]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [367]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [367]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [348]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [185]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [369]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By L-selectin (SELL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [370]
Meloxicam DM2AR7L Arthritis FA20 Approved [370]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [348]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [371]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [370]
Nabumetone DMAT2XH Osteoarthritis FA00-FA05 Approved [370]
Phenylbutazone DMAYL0T Chronic pain MG30 Approved [370]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Flufenamic Acid DMC8VNH Dysmenorrhea GA34.3 Approved [370]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hepatocyte growth factor (HGF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [190]
Quercetin DM3NC4M Obesity 5B81 Approved [372]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [373]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [373]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [374]
Etodolac DM6WJO9 Osteoarthritis FA00-FA05 Approved [375]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [376]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [374]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Quercetin DM3NC4M Obesity 5B81 Approved [378]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [11]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [379]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [380]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [381]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [180]
Gefitinib DM15F0X Colon adenocarcinoma Approved [199]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Selenium DM25CGV N. A. N. A. Approved [305]
Pentosan Polysulfate DM2HRKE Interstitial cystitis GC00.3 Approved [382]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [322]
Methotrexate DM2TEOL Anterior urethra cancer Approved [160]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [383]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [384]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [385]
Gefitinib DM15F0X Colon adenocarcinoma Approved [199]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [386]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [387]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [388]
Asasantin DMCZIHT Cerebrovascular ischaemia 8B1Z Approved [389]
Folic Acid DMEMBJC Colorectal carcinoma Approved [390]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [391]
Vitamin B3 DMQVRZH Chronic renal failure GB61.Z Approved [392]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [393]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Selenium DM25CGV N. A. N. A. Approved [394]
Methotrexate DM2TEOL Anterior urethra cancer Approved [395]
Quercetin DM3NC4M Obesity 5B81 Approved [247]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [125]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [248]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [396]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [397]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [250]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [398]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [399]
Methotrexate DM2TEOL Anterior urethra cancer Approved [400]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [401]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [402]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [184]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-2 (CDH2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [190]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [183]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [404]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [405]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [406]
Testosterone DM7HUNW Hot flushes GA30 Approved [407]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [408]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [409]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [410]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Quercetin DM3NC4M Obesity 5B81 Approved [163]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [411]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [412]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [413]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [414]
Quercetin DM3NC4M Obesity 5B81 Approved [378]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [221]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [413]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [11]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [415]
Ethanol DMDRQZU Chronic pain MG30 Approved [327]
Menthol DMG2KW7 Back pain ME84.Z Approved [135]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [235]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Diazepam DM08E9O Alcohol withdrawal Approved [416]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [417]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [351]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [415]
Ethanol DMDRQZU Chronic pain MG30 Approved [419]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-10 (IL10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [227]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [202]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [420]
Methotrexate DM2TEOL Anterior urethra cancer Approved [421]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [422]
Quercetin DM3NC4M Obesity 5B81 Approved [423]
Bisoprolol DM3UZ95 Hypertension BA00-BA04 Approved [424]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [207]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [425]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [426]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [427]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [185]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [351]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [428]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [429]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [398]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [427]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Febuxostat DMDEXQ0 Hyperuricaemia 5C55.Y Approved [430]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [431]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [432]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [415]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Folic Acid DMEMBJC Colorectal carcinoma Approved [354]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [433]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [434]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [435]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [436]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [346]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [437]
Gefitinib DM15F0X Colon adenocarcinoma Approved [438]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [439]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [347]
Selenium DM25CGV N. A. N. A. Approved [368]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [440]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [441]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [442]
Teriflunomide DMQ2FKJ Hyperlipidaemia 5C80 Approved [443]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [444]
Arsenic DMTL2Y1 N. A. N. A. Approved [445]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [446]
PBI-05204 DM05WIU Pancreatic cancer 2C10 Phase 2 [447]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [368]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [448]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [449]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [450]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [451]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [452]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [453]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [454]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [455]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [446]
PBI-05204 DM05WIU Pancreatic cancer 2C10 Phase 2 [447]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [262]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [190]
Selenium DM25CGV N. A. N. A. Approved [368]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [456]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [457]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [11]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [458]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [158]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [398]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [319]
Methotrexate DM2TEOL Anterior urethra cancer Approved [459]
Epinephrine DM3KJBC Acute asthma CA23 Approved [460]
Quercetin DM3NC4M Obesity 5B81 Approved [461]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [462]
Fructose DM43AN2 Vomiting MD90 Approved [463]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [158]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [464]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [465]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Gefitinib DM15F0X Colon adenocarcinoma Approved [211]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [464]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [466]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [467]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [468]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [469]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [470]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Folic Acid DMEMBJC Colorectal carcinoma Approved [433]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [471]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [472]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [473]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [197]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [474]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [475]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [476]
Gefitinib DM15F0X Colon adenocarcinoma Approved [477]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [478]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [479]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [480]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [472]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [481]
Paclitaxel DMLB81S Breast carcinoma Approved [482]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [483]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [471]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [197]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [474]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [484]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [485]
Methotrexate DM2TEOL Anterior urethra cancer Approved [421]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [486]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [349]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Capivasertib DM9SKW8 Breast cancer 2C60-2C65 Approved [487]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [488]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [242]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [346]
Gefitinib DM15F0X Colon adenocarcinoma Approved [489]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [490]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [491]
Selenium DM25CGV N. A. N. A. Approved [368]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [246]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [440]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [492]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [493]
Gamolenic acid DMQN30Z Allergy 4A80-4A85 Approved [494]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [495]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [496]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [497]
Ibandronate DM0QZBN Hypercalcaemia 5B91.0 Approved [498]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [180]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [212]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [499]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Triacetin DM0AEPG Onychomycosis EE12.1 Approved [500]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [145]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [501]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [398]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [502]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [503]
Methotrexate DM2TEOL Anterior urethra cancer Approved [173]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [409]
Diazepam DM08E9O Alcohol withdrawal Approved [416]
Quercetin DM3NC4M Obesity 5B81 Approved [504]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [221]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [505]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [11]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [506]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [507]
Selenium DM25CGV N. A. N. A. Approved [368]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [508]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [11]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [497]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [509]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [510]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [511]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [512]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [513]
Quercetin DM3NC4M Obesity 5B81 Approved [514]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glutamate receptor 3 (GRIA3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [515]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [516]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [517]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [518]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [519]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [140]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [455]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [520]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [521]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [522]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [239]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [523]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [524]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [525]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [526]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [527]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [528]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [529]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [433]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [530]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [531]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [140]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [380]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [315]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [532]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [433]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [533]
Methotrexate DM2TEOL Anterior urethra cancer Approved [173]
Quercetin DM3NC4M Obesity 5B81 Approved [534]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [125]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [486]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [535]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [349]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [536]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Propranolol DM79NTF Angina pectoris BA40 Approved [155]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Gefitinib DM15F0X Colon adenocarcinoma Approved [537]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [538]
Epinephrine DM3KJBC Acute asthma CA23 Approved [460]
Quercetin DM3NC4M Obesity 5B81 Approved [539]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [229]
Fructose DM43AN2 Vomiting MD90 Approved [463]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [540]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [541]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [165]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glutamate receptor 4 (GRIA4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Folic Acid DMEMBJC Colorectal carcinoma Approved [354]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [543]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [458]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Homeobox protein MOX-1 (MEOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [158]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [530]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [145]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [158]
Selenium DM25CGV N. A. N. A. Approved [368]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [544]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [545]
Methotrexate DM2TEOL Anterior urethra cancer Approved [160]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [229]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [546]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [396]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FosB (FOSB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [348]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [185]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [547]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [183]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [517]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [548]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [315]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [455]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
PMID25656651-Compound-5 DMAI95U Chronic myeloid leukaemia 2A20 Patented [549]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [550]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [377]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [380]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Dolutegravir DMCZGRE Human immunodeficiency virus infection 1C62 Approved [551]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Folic Acid DMEMBJC Colorectal carcinoma Approved [354]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-9 (CASP9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [552]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [553]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [345]
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [554]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [555]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [319]
Meloxicam DM2AR7L Arthritis FA20 Approved [556]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [557]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [558]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-6 (CDH6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [431]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [315]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [559]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [271]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [560]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sorting nexin-16 (SNX16)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [561]
Urethane DM7NSI0 N. A. N. A. Phase 4 [141]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [562]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [380]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [153]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurexin-1-beta (NRXN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [563]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [564]
Arsenic DMTL2Y1 N. A. N. A. Approved [137]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [455]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [565]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [377]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [458]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [242]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [566]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [567]
Quercetin DM3NC4M Obesity 5B81 Approved [568]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [569]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome c (CYCS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [570]
Gefitinib DM15F0X Colon adenocarcinoma Approved [317]
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [554]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [571]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [572]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [573]
Pefloxacin DM49IGF Gonococcal urethritis 1A70.0Y Approved [574]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [575]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Quercetin DM3NC4M Obesity 5B81 Approved [378]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Angiopoietin-1 receptor (TEK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [11]
Propranolol DM79NTF Angina pectoris BA40 Approved [155]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Capsaicin DMGMF6V Back pain ME84.Z Approved [576]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [577]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [271]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [578]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [579]
Rigosertib DMOSTXF Myelodysplastic syndrome 2A37 Phase 3 [580]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [263]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [517]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [235]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [581]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [582]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [168]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Butorphanol DM5KYPJ Pain MG30-MG3Z Approved [583]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [584]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [585]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [586]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [587]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [268]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Bcl-2-like protein 1 (BCL2L1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [242]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [588]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [319]
Selenium DM25CGV N. A. N. A. Approved [368]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [589]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [590]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [162]
Quercetin DM3NC4M Obesity 5B81 Approved [163]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [229]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [197]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [158]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [591]
Methotrexate DM2TEOL Anterior urethra cancer Approved [160]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [592]
Quercetin DM3NC4M Obesity 5B81 Approved [461]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [593]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [158]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [594]
Ethacrynic acid DM60QMR Edema MG29 Approved [166]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [178]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [178]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [178]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [178]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [595]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [596]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [458]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
Chlorothiazide DMLHESP Chronic heart failure BD1Z Approved [597]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [153]
APR-246 DMNFADH Ovarian cancer 2C73 Phase 2 [598]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Selenium DM25CGV N. A. N. A. Approved [368]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Febuxostat DMDEXQ0 Hyperuricaemia 5C55.Y Approved [430]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [431]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Arsenic DMTL2Y1 N. A. N. A. Approved [599]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-8 (CASP8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [600]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [601]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [602]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [144]
Gefitinib DM15F0X Colon adenocarcinoma Approved [537]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [603]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [319]
Selenium DM25CGV N. A. N. A. Approved [368]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [557]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [398]
Methotrexate DM2TEOL Anterior urethra cancer Approved [123]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Menthol DMG2KW7 Back pain ME84.Z Approved [135]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [168]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [452]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [398]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [455]
Urethane DM7NSI0 N. A. N. A. Phase 4 [141]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [604]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [605]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [466]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [606]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Racecadotril DMFOTZ7 Diarrhea ME05.1 Approved [607]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [434]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [608]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [516]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [484]
Methotrexate DM2TEOL Anterior urethra cancer Approved [421]
Quercetin DM3NC4M Obesity 5B81 Approved [609]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [348]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [349]
Ethacrynic acid DM60QMR Edema MG29 Approved [610]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [611]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [612]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Arsenic DMTL2Y1 N. A. N. A. Approved [137]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [169]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [613]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [613]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [455]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [614]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [615]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [433]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Ethanol DMDRQZU Chronic pain MG30 Approved [616]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [617]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [380]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [431]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Complexin-3 (CPLX3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [582]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [169]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
Milchsaure DM462BT Pruritus EC90 Investigative [618]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [229]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [464]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [619]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [620]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [268]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [403]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tribbles homolog 3 (TRIB3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [184]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [427]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [464]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [621]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [464]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Eyes absent homolog 1 (EYA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [377]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [178]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [187]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [178]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [178]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Synaptotagmin-15 (SYT15)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Folic Acid DMEMBJC Colorectal carcinoma Approved [354]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [622]
Urethane DM7NSI0 N. A. N. A. Phase 4 [141]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [623]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [624]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Neurogenin-2 (NEUROG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [178]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [178]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [178]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Dabigatran DMDI6R4 Stroke 8B20 Approved [178]
Folic Acid DMEMBJC Colorectal carcinoma Approved [433]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [178]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Synaptotagmin-4 (SYT4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [530]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [153]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [377]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [458]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Frizzled-8 (FZD8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [625]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [626]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [627]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [586]
Camptothecin DM6CHNJ Solid tumour/cancer 2A00-2F9Z Phase 3 [628]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [153]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [629]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [629]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [629]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [629]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [629]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [630]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [235]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [629]
Ziprasidone DMM58JY Bipolar disorder 6A60 Approved [629]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [631]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [167]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [154]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [632]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [452]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [167]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [633]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [353]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [634]
Arsenic DMTL2Y1 N. A. N. A. Approved [635]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
Urethane DM7NSI0 N. A. N. A. Phase 4 [141]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [140]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [636]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [637]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [638]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Panobinostat DM58WKG Chronic graft versus host disease Approved [639]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [399]
Testosterone DM7HUNW Hot flushes GA30 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [379]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [640]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [380]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [466]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [171]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [177]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [177]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [606]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [458]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [177]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [577]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [171]
Selenium DM25CGV N. A. N. A. Approved [368]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [229]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [464]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [403]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [350]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [641]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [171]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sal-like protein 4 (SALL4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [642]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [643]
Pomalidomide DMTGBAX Plasma cell myeloma 2A83.1 Approved [642]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [271]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [644]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [637]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [172]
Methotrexate DM2TEOL Anterior urethra cancer Approved [421]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [248]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [464]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [248]
Panobinostat DM58WKG Chronic graft versus host disease Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [464]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [379]
Leflunomide DMR8ONJ Arthritis FA20 Approved [133]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [210]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [248]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [645]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [387]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [468]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [379]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [646]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [187]
Diazepam DM08E9O Alcohol withdrawal Approved [416]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [647]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [648]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [649]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [152]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [174]
Isradipine DMA5XGH Hypertension BA00-BA04 Approved [650]
Valdecoxib DMAY7H4 Osteoarthritis FA00-FA05 Approved [651]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Thrombomodulin (THBD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [652]
Methotrexate DM2TEOL Anterior urethra cancer Approved [149]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [653]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [427]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [530]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [352]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [94]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [654]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [655]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [452]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [656]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [657]
Quercetin DM3NC4M Obesity 5B81 Approved [124]
Fluoxetine DM3PD2C Bipolar depression Approved [658]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [221]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [659]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [660]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [661]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [662]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [663]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [534]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [132]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [170]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [400]
Urethane DM7NSI0 N. A. N. A. Phase 4 [141]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [636]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [664]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [665]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [666]
Methotrexate DM2TEOL Anterior urethra cancer Approved [182]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [667]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [175]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [668]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [669]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [670]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 3A7 (CYP3A7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [248]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [93]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [92]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [671]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [672]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [673]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [106]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [674]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [675]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [221]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [676]
Dicloxacillin DM8EU0Z Bacterial infection 1A00-1C4Z Approved [676]
Ergonovine DM0VEC1 Postpartum haemorrhage JA43 Approved [112]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [677]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [678]
Mizolastine DM1FDN8 Allergic rhinitis CA08.0 Approved [679]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [227]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [680]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [681]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [364]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein cereblon (CRBN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [368]
Testosterone DM7HUNW Hot flushes GA30 Approved [225]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [314]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [136]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [561]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [682]
Pomalidomide DMTGBAX Plasma cell myeloma 2A83.1 Approved [682]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [542]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [623]
Milchsaure DM462BT Pruritus EC90 Investigative [618]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tumor necrosis factor (TNF) TTF8CQI TNFA_HUMAN Inhibitor [4]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 2E1 (CYP2E1) DEVDYN7 CP2E1_HUMAN Substrate [5]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Substrate [6]
Mephenytoin 4-hydroxylase (CYP2C19) DEGTFWK CP2CJ_HUMAN Substrate [7]
Cytochrome P450 2A6 (CYP2A6) DEJVYAZ CP2A6_HUMAN Substrate [8]
Cytochrome P450 3A5 (CYP3A5) DEIBDNY CP3A5_HUMAN Substrate [9]
Cytochrome P450 2B6 (CYP2B6) DEPKLMQ CP2B6_HUMAN Substrate [8]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Substrate [6]
Prostaglandin G/H synthase 1 (COX-1) DE073H6 PGH1_HUMAN Substrate [5]
Cytochrome P450 2C18 (CYP2C18) DEZMWRE CP2CI_HUMAN Substrate [6]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
72 kDa type IV collagenase (MMP2) OT5NIWA2 MMP2_HUMAN Gene/Protein Processing [10]
Angiopoietin-1 receptor (TEK) OT78YN57 TIE2_HUMAN Gene/Protein Processing [11]
Angiopoietin-2 (ANGPT2) OTEQK65P ANGP2_HUMAN Gene/Protein Processing [12]
Annexin A2 (ANXA2) OTFNS0CC ANXA2_HUMAN Gene/Protein Processing [13]
Apoptosis regulator Bcl-2 (BCL2) OT9DVHC0 BCL2_HUMAN Gene/Protein Processing [14]
ATP-dependent translocase ABCB1 (ABCB1) OTEJROBO MDR1_HUMAN Gene/Protein Processing [15]
Bcl-2-like protein 1 (BCL2L1) OTRC5K9O B2CL1_HUMAN Gene/Protein Processing [16]
C-C motif chemokine 2 (CCL2) OTAD2HEL CCL2_HUMAN Gene/Protein Processing [17]
C-reactive protein (CRP) OT0RFT8F CRP_HUMAN Gene/Protein Processing [18]
C-X-C chemokine receptor type 1 (CXCR1) OT5512B2 CXCR1_HUMAN Gene/Protein Processing [19]

References

1 Thalidomide FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7327).
3 ClinicalTrials.gov (NCT04273529) The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia. U.S. National Institutes of Health.
4 Efficacy of different thalidomide regimens for patients with multiple myeloma and its relationship with TNF-alpha level. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1312-5.
5 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
6 Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res. 2002 Jun;8(6):1964-73.
7 Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide. Cancer Biol Ther. 2002 Nov-Dec;1(6):669-73.
8 Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients. J Biochem Mol Toxicol. 2000;14(3):140-7.
9 Human liver microsomal cytochrome P450 3A enzymes involved in thalidomide 5-hydroxylation and formation of a glutathione conjugate. Chem Res Toxicol. 2010 Jun 21;23(6):1018-24.
10 Effects of thalidomide on parameters involved in angiogenesis: an in vitro study. J Neurooncol. 2003 Sep;64(3):193-201. doi: 10.1023/a:1025618022921.
11 Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood. 2005 Apr 15;105(8):3286-94. doi: 10.1182/blood-2004-06-2101. Epub 2004 Dec 23.
12 Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol. 2005 Aug 10;23(23):5334-46. doi: 10.1200/JCO.2005.03.723. Epub 2005 Jun 6.
13 [Effects of thalidomide on Annexin II gene regulation]. Zhonghua Xue Ye Xue Za Zhi. 2009 Jul;30(7):464-7.
14 Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis. Vascul Pharmacol. 2005 Aug;43(2):112-9. doi: 10.1016/j.vph.2005.04.003.
15 Long-term thalidomide therapy resulted in lack of mdr1 gene expression in a patient with primary resistant multiple myeloma. Leukemia. 2005 Aug;19(8):1497-9. doi: 10.1038/sj.leu.2403811.
16 NF-kappaB protects Beh?et's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Arthritis Rheum. 2005 Jul;52(7):2179-91. doi: 10.1002/art.21145.
17 Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis. 2010 Jun 2;9:56. doi: 10.1186/1476-511X-9-56.
18 Intractable insomnia after cessation of treatment with thalidomide. Gastroenterology. 2001 May;120(6):1567-8. doi: 10.1053/gast.2001.24495.
19 Immunological consequences of thalidomide treatment in Sj?gren's syndrome. Ann Rheum Dis. 2006 Jan;65(1):112-4. doi: 10.1136/ard.2005.038406.
20 Clinical pipeline report, company report or official report of AstraZeneca (2009).
21 Targeted therapies in myelodysplastic syndromes: ASH 2003 review. Semin Hematol. 2004 Apr;41(2 Suppl 4):13-20.
22 Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007351.
23 Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes : a potential treatment for aseptic loose... J Bone Joint Surg Am. 2001 Jul;83(7):1057-61.
24 Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
25 Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
26 The potential of biologics for the treatment of asthma. Nat Rev Drug Discov. 2012 Dec;11(12):958-72.
27 Adalimumab for psoriasis patients who are non-responders to etanercept: open-label prospective evaluation. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1394-7.
28 Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2008 Jun;4(6):300-9.
29 TNFerade, an adenovector carrying the transgene for human tumor necrosis factor alpha, for patients with advanced solid tumors: surgical experience... Ann Surg Oncol. 2005 Oct;12(10):825-30.
30 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
31 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
32 Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 1994 Jan;15(1):5-9.
33 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
34 Psychotropic drug interactions with valproate. Clin Neuropharmacol. 2005 Mar-Apr;28(2):96-101.
35 The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos. 2013 Sep;41(9):1686-94.
36 Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998 Jun;80(6):788-95.
37 CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine delta-5'(1')iminium ion. J Pharmacol Exp Ther. 2012 Nov;343(2):307-15.
38 Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer. J Urol. 2008 Dec;180(6):2389-95.
39 Human prostate CYP3A5: identification of a unique 5'-untranslated sequence and characterization of purified recombinant protein. Biochem Biophys Res Commun. 1999 Jul 14;260(3):676-81.
40 Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. Cancer Lett. 2005 Jan 10;217(1):61-72.
41 Drug Interactions Flockhart Table
42 Induction of hepatic CYP2E1 by a subtoxic dose of acetaminophen in rats: increase in dichloromethane metabolism and carboxyhemoglobin elevation. Drug Metab Dispos. 2007 Oct;35(10):1754-8.
43 Urinary 6 beta-hydroxycortisol excretion in rheumatoid arthritis. Br J Rheumatol. 1997 Jan;36(1):54-8.
44 Clinical pharmacokinetics of imatinib. Clin Pharmacokinet. 2005;44(9):879-94.
45 Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab Dispos. 2004 Sep;32(9):993-1000.
46 Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil. Drug Metab Dispos. 2005 May;33(5):664-71.
47 Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am J Physiol Gastrointest Liver Physiol. 2005 Jul;289(1):G54-63.
48 Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int. 2003 May;63(5):1687-96.
49 Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic Res. 2010 Mar;44(3):340-55.
50 A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J Pharmacol Exp Ther. 1998 Sep;286(3):1294-300.
51 The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ. 2007 Aug 1;381(1-3):38-46.
52 Novel metabolic pathway of estrone and 17beta-estradiol catalyzed by cytochrome P-450. Drug Metab Dispos. 2000 Feb;28(2):110-2.
53 Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes. Biochem Pharmacol. 2002 Oct 1;64(7):1151-6.
54 CYP2E1 and clinical features in alcoholics. Neuropsychobiology. 2003;47(2):86-9.
55 Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70.
56 Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol. 2000 Dec;58(6):1341-8.
57 Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C51. Arch Biochem Biophys. 1997 Feb 15;338(2):157-64.
58 Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol. 1996 Mar;9(2):365-73.
59 CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone. Drug Metab Dispos. 2000 Aug;28(8):865-8.
60 Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos. 2001 Mar;29(3):242-51.
61 Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev. 2016 Jan;68(1):168-241.
62 Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmacogenetics. 2003 Sep;13(9):565-75.
63 Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants. Biochemistry. 2004 Dec 14;43(49):15379-92.
64 Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study. Cancer Chemother Pharmacol. 2011 Nov;68(5):1111-8.
65 PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014 Jan;24(1):73-9.
66 Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9.
67 Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients. J Chemother. 2006 Aug;18(4):421-4.
68 Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
69 Drug-drug interactions with imatinib: an observational study. Medicine (Baltimore). 2016 Oct;95(40):e5076.
70 Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 2000 Feb;28(2):125-30.
71 New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Curr Drug Metab. 2009 Dec;10(10):1075-126.
72 A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat. 2003 Dec;82(3):191-7.
73 A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998 May;32(5):554-63.
74 Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6. J Pharmacol Exp Ther. 2002 Jun;301(3):945-52.
75 Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96.
76 Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016 Sep;6(5):413-425.
77 Drugs that may have potential CYP2B6 interactions.
78 Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica. 2007 Jul;37(7):717-24.
79 Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6. Drug Metab Dispos. 2005 Dec;33(12):1760-4.
80 PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012 Jun;22(6):466-70.
81 Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol Exp Ther. 2001 Apr;297(1):326-37.
82 High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Hepatogastroenterology. 2003 Nov-Dec;50(54):2274-8.
83 Cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006 Mar 13;25(11):1679-91.
84 CYP2C19*17 is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2009 May;115(2):391-6.
85 Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):116-21.
86 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.
87 Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26). Biochem Biophys Res Commun. 1986 Feb 26;135(1):215-20.
88 The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism. Toxicol Lett. 2019 Oct 15;315:9-13.
89 Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
90 Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91.
91 Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos. 2005 Jul;33(7):1074-81. doi: 10.1124/dmd.104.002279. Epub 2005 Apr 8.
92 Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):86-96.
93 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
94 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
95 Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines. Drug Metab Dispos. 2013 Feb;41(2):281-90.
96 Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am J Respir Cell Mol Biol. 2000 Mar;22(3):360-6.
97 Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicol Lett. 2016 Jan 22;241:82-94.
98 Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact. 2016 Aug 5;255:31-44.
99 Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2002 May;122(5):339-61.
100 Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem. 2004 Jul 9;279(28):29295-301. doi: 10.1074/jbc.M400580200. Epub 2004 Apr 28.
101 Identification of novel agonists by high-throughput screening and molecular modelling of human constitutive androstane receptor isoform 3. Arch Toxicol. 2019 Aug;93(8):2247-2264. doi: 10.1007/s00204-019-02495-6. Epub 2019 Jul 16.
102 Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol. 2005 Jun;67(6):1954-65.
103 Characterization of human cytochrome P450 induction by pesticides. Toxicology. 2012 Mar 29;294(1):17-26.
104 Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. Arch Biochem Biophys. 2005 Feb 1;434(1):75-85.
105 Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes. Drug Metabol Drug Interact. 2008;23(3-4):211-36.
106 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
107 Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact. 2004 Apr 15;147(3):331-40.
108 The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
109 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
110 Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
111 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
112 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
113 Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60.
114 Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5591-4.
115 Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010 Mar;29(2 Suppl):22S-6S.
116 Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS. Chem Biol Interact. 2019 Sep 1;310:108744. doi: 10.1016/j.cbi.2019.108744. Epub 2019 Jul 9.
117 Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.
118 Induction of PXR-mediated metabolism by beta-carotene. Biochim Biophys Acta. 2005 May 30;1740(2):162-9. doi: 10.1016/j.bbadis.2004.11.013. Epub 2004 Dec 8.
119 Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol. 2005 Dec 1;209(2):123-33. doi: 10.1016/j.taap.2005.03.015.
120 Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening. Drug Metab Dispos. 2011 Feb;39(2):337-44. doi: 10.1124/dmd.110.035808. Epub 2010 Nov 10.
121 Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos. 2005 Jul;33(7):924-9.
122 Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor. Toxicol Lett. 2017 Jan 4;265:86-96.
123 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
124 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
125 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
126 Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis. Leuk Res. 2006 May;30(5):607-23. doi: 10.1016/j.leukres.2005.09.007. Epub 2005 Oct 19.
127 Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One. 2011;6(11):e27306. doi: 10.1371/journal.pone.0027306. Epub 2011 Nov 8.
128 Bupropion, an atypical antidepressant, induces endoplasmic reticulum stress and caspase-dependent cytotoxicity in SH-SY5Y cells. Toxicology. 2011 Jul 11;285(1-2):1-7. doi: 10.1016/j.tox.2011.02.006. Epub 2011 Feb 24.
129 Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells. Asian Pac J Cancer Prev. 2013;14(11):6469-73. doi: 10.7314/apjcp.2013.14.11.6469.
130 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
131 Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo. Environ Toxicol. 2017 Mar;32(3):723-738. doi: 10.1002/tox.22273. Epub 2016 Apr 25.
132 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
133 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
134 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
135 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
136 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
137 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
138 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
139 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.
140 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
141 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
142 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
143 Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine, a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis. Oncol Rep. 2007 Sep;18(3):523-9.
144 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
145 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
146 Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics. 2008 Aug 7;9:376.
147 Death receptor 5 regulation during selenium-mediated apoptosis in human prostate cancer cells. Cancer Biol Ther. 2002 May-Jun;1(3):287-90. doi: 10.4161/cbt.83.
148 Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.
149 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
150 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
151 Effects of methotrexate on vascular endothelial growth factor, angiopoietin 1, and angiopoietin 2 in nasal polyps. Am J Rhinol Allergy. 2011 Jul-Aug;25(4):e129-32. doi: 10.2500/ajra.2011.25.3618.
152 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
153 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
154 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
155 Propranolol inhibits proliferation and induces apoptosis of hemangioma-derived endothelial cells via Akt pathway by down-regulating Ang-2 expression. Chem Biol Interact. 2020 Jan 25;316:108925. doi: 10.1016/j.cbi.2019.108925. Epub 2019 Dec 12.
156 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
157 Atorvastatin affects several angiogenic mediators in human endothelial cells. Endothelium. 2005 Sep-Dec;12(5-6):233-41.
158 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
159 PGK1 induction by a hydrogen peroxide treatment is suppressed by antioxidants in human colon carcinoma cells. Biosci Biotechnol Biochem. 2008 Jul;72(7):1799-808. doi: 10.1271/bbb.80079. Epub 2008 Jul 7.
160 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
161 Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells. Clin Cancer Res. 2001 Feb;7(2):407-14.
162 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.
163 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
164 Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. Apoptosis. 2006 Sep;11(9):1503-12. doi: 10.1007/s10495-006-8896-3.
165 Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis. J Clin Immunol. 2002 Jan;22(1):37-47. doi: 10.1023/a:1014256603539.
166 Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Clin Cancer Res. 2012 Dec 15;18(24):6690-701. doi: 10.1158/1078-0432.CCR-12-0770. Epub 2012 Oct 18.
167 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
168 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
169 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
170 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
171 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
172 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
173 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
174 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
175 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
176 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
177 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
178 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
179 The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact. 2012 Jan 5;195(1):52-60.
180 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
181 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
182 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
183 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
184 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
185 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
186 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
187 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
188 Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro. Toxicol Sci. 2003 Aug;74(2):260-70. doi: 10.1093/toxsci/kfg113. Epub 2003 May 2.
189 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
190 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
191 Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937. Arthritis Res Ther. 2014 Jan 20;16(1):R17. doi: 10.1186/ar4444.
192 Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation. Cardiovasc Res. 2005 Aug 1;67(2):333-41. doi: 10.1016/j.cardiores.2005.03.016. Epub 2005 Apr 21.
193 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004 Jun 25;279(26):27008-16. doi: 10.1074/jbc.M403588200. Epub 2004 Apr 16.
194 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
195 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
196 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
197 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
198 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
199 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
200 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
201 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
202 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res. 2003 Aug;23(8):423-31. doi: 10.1089/107999003322277838.
203 Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. Antiviral Res. 2007 Jul;75(1):36-42. doi: 10.1016/j.antiviral.2006.11.008. Epub 2006 Dec 13.
204 Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother. 2005 Sep;56(3):502-6. doi: 10.1093/jac/dki251. Epub 2005 Jul 8.
205 Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J Immunol. 2008 May 15;180(10):6988-96. doi: 10.4049/jimmunol.180.10.6988.
206 The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta. 2002 Dec 16;1593(1):29-36. doi: 10.1016/s0167-4889(02)00328-2.
207 [Effects of vitamin A on the differentiation, maturation and functions of dendritic cells from cord blood]. Zhonghua Er Ke Za Zhi. 2004 May;42(5):340-3.
208 Effect of zidovudine therapy in patients with HIV infection on endogenous interferon plasma levels and the hepatic cytochrome P450 enzyme system. Chemotherapy. 1998 May-Jun;44(3):174-80. doi: 10.1159/000007112.
209 Detection of Drug-Responsive T-Lymphocytes in a Case of Fatal Antituberculosis Drug-Related Liver Injury. Chem Res Toxicol. 2016 Nov 21;29(11):1793-1795. doi: 10.1021/acs.chemrestox.6b00393. Epub 2016 Nov 9.
210 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
211 Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction. J Toxicol Sci. 2020;45(11):673-680. doi: 10.2131/jts.45.673.
212 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
213 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
214 (9)-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture. J Pharmacol Exp Ther. 2019 Oct;371(1):191-201. doi: 10.1124/jpet.119.260661. Epub 2019 Aug 5.
215 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
216 Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. Arch Toxicol. 2018 Jun;92(6):2043-2054. doi: 10.1007/s00204-018-2199-7. Epub 2018 Mar 29.
217 Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis. 2006 Apr;11(4):573-9. doi: 10.1007/s10495-006-4919-3.
218 C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. AIDS. 2004 Dec 3;18(18):2434-7.
219 Simvastatin combined with ramipril treatment in hypercholesterolemic patients. Hypertension. 2004 Aug;44(2):180-5. doi: 10.1161/01.HYP.0000133310.42762.25. Epub 2004 Jun 7.
220 The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 2007 Feb 28;557(2-3):221-9.
221 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
222 Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci Immunol. 2020 Jun 5;5(48):eabd0110. doi: 10.1126/sciimmunol.abd0110. Epub 2020 Jun 5.
223 The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis. Curr Med Res Opin. 1975;3(5):286-97. doi: 10.1185/03007997509114779.
224 Effects of hormone treatment on hemostasis variables. Climacteric. 2007 Oct;10 Suppl 2:32-7. doi: 10.1080/13697130701598548.
225 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
226 The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg. 2002 Jan;94(1):22-30, table of contents. doi: 10.1097/00000539-200201000-00005.
227 Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant. J Dermatol Sci. 2001 Jun;26(2):85-93. doi: 10.1016/s0923-1811(00)00165-1.
228 Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy. 2000 Apr;30(4):501-8. doi: 10.1046/j.1365-2222.2000.00768.x.
229 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
230 Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence. Mol Vis. 2013;19:718-28. Epub 2013 Mar 21.
231 Human corneal epithelial cell functional responses to inflammatory agents and their antagonists. Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2562-71.
232 Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis. Mol Immunol. 2015 Feb;63(2):521-9. doi: 10.1016/j.molimm.2014.10.008.
233 Acetylcholine and nicotine stimulate the release of granulocyte-macrophage colony stimulating factor from cultured human bronchial epithelial cells. Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):472-5. doi: 10.1007/pl00005195.
234 Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells. Mol Cell Endocrinol. 2008 Jun 11;287(1-2):57-64. doi: 10.1016/j.mce.2008.01.015. Epub 2008 Feb 3.
235 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
236 p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis. Int J Cancer. 2005 Apr 10;114(3):331-6. doi: 10.1002/ijc.20818.
237 Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):89-97. doi: 10.1016/j.taap.2006.04.015. Epub 2006 May 19.
238 Quantitative analysis of gene expression changes in response to genotoxic compounds. Toxicol In Vitro. 2017 Mar;39:15-28. doi: 10.1016/j.tiv.2016.11.004. Epub 2016 Nov 5.
239 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
240 Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line. J Biochem Mol Toxicol. 2021 Feb;35(2):e22638. doi: 10.1002/jbt.22638. Epub 2020 Oct 1.
241 Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. Nucleic Acids Res. 2009 Jan;37(1):78-95. doi: 10.1093/nar/gkn910. Epub 2008 Nov 16.
242 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
243 Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes. Chem Res Toxicol. 2022 Apr 18;35(4):636-650. doi: 10.1021/acs.chemrestox.1c00420. Epub 2022 Mar 21.
244 Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex. Br J Cancer. 2013 Nov 12;109(10):2751-62. doi: 10.1038/bjc.2013.583. Epub 2013 Oct 29.
245 Insulin-like growth factors (IGF) I and II utilize different calcium signaling pathways in a primary human parathyroid cell culture model. World J Surg. 2006 Mar;30(3):333-45. doi: 10.1007/s00268-005-0339-8.
246 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
247 Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3). Mol Cell Biochem. 2010 Nov;344(1-2):173-84. doi: 10.1007/s11010-010-0540-4. Epub 2010 Jul 25.
248 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
249 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
250 DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Am J Physiol Endocrinol Metab. 2006 May;290(5):E952-60. doi: 10.1152/ajpendo.00451.2005. Epub 2005 Dec 20.
251 Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: a microarray study. J Nutrigenet Nutrigenomics. 2008;1(1-2):30-48. doi: 10.1159/000109873. Epub 2007 Oct 16.
252 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
253 Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer. 2010 Jul;46(10):1848-55. doi: 10.1016/j.ejca.2010.03.026. Epub 2010 Apr 17.
254 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
255 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
256 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
257 Blood cell oxidative stress precedes hemolysis in whole blood-liver slice co-cultures of rat, dog, and human tissues. Toxicol Appl Pharmacol. 2010 May 1;244(3):354-65. doi: 10.1016/j.taap.2010.01.017. Epub 2010 Feb 6.
258 High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 1993 Nov 15;82(10):3133-40.
259 Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples. Data Brief. 2016 Mar 26;7:1052-1057. doi: 10.1016/j.dib.2016.03.069. eCollection 2016 Jun.
260 Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020 Feb 14;10(1):2687. doi: 10.1038/s41598-020-59468-4.
261 Nitrogen mustard prevents transport of Fra-1 into the nucleus to promote c-Fos- and FosB-dependent IL-8 induction in injured mouse epidermis. Toxicol Lett. 2020 Feb 1;319:256-263. doi: 10.1016/j.toxlet.2019.10.006. Epub 2019 Oct 19.
262 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
263 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
264 Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. J Biol Chem. 2002 Nov 15;277(46):43648-58. doi: 10.1074/jbc.M203214200. Epub 2002 Sep 6.
265 [Regulation mechanism of autophagy-related protein LC3 by c-Jun in methotrexate resistant human choriocarcinoma JEG-3 cells]. Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):531-5.
266 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
267 Calbindin-D28k (CaBP28k) identification and regulation by 1,25-dihydroxyvitamin D3 in human choriocarcinoma cell line JEG-3. Mol Cell Endocrinol. 2005 May 31;236(1-2):31-41. doi: 10.1016/j.mce.2005.03.002. Epub 2005 Apr 12.
268 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
269 In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicol Lett. 2013 Mar 13;217(3):235-42. doi: 10.1016/j.toxlet.2012.12.015. Epub 2012 Dec 31.
270 ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer. 2006 Jan 15;118(2):483-9. doi: 10.1002/ijc.21340.
271 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
272 Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression. Clin Chim Acta. 2001 Oct;312(1-2):213-9. doi: 10.1016/s0009-8981(01)00626-x.
273 Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res. 2004 Jan 1;64(1):19-22. doi: 10.1158/0008-5472.can-03-2789.
274 Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis. 2001 Mar;22(3):409-14. doi: 10.1093/carcin/22.3.409.
275 EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer. Oncotarget. 2015 Feb 28;6(6):3811-24.
276 Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Prostate. 2007 Aug 1;67(11):1152-62. doi: 10.1002/pros.20585.
277 Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo. Prostate. 2009 May 15;69(7):744-54. doi: 10.1002/pros.20923.
278 Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. Prostate. 2010 Oct 1;70(14):1575-85. doi: 10.1002/pros.21193.
279 Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth. J Urol. 2006 Jul;176(1):354-60. doi: 10.1016/S0022-5347(06)00516-7.
280 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
281 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
282 Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator. Thromb Res. 2002 Apr 1;106(1):63-70. doi: 10.1016/s0049-3848(02)00075-0.
283 [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2009 Mar;30(3):145-9.
284 Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull. 2007 Feb;30(2):247-53. doi: 10.1248/bpb.30.247.
285 Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics. 2008 Apr;8(8):1595-607. doi: 10.1002/pmic.200700556.
286 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
287 Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res. 2010 Aug 1;316(13):2174-88. doi: 10.1016/j.yexcr.2010.04.027. Epub 2010 May 8.
288 Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem Pharmacol. 2008 May 15;75(10):1946-58. doi: 10.1016/j.bcp.2008.02.016. Epub 2008 Mar 10.
289 Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L419-28. doi: 10.1152/ajplung.00002.2005. Epub 2005 May 20.
290 Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther. 2012 Nov;11(11):2483-94. doi: 10.1158/1535-7163.MCT-12-0580. Epub 2012 Aug 21.
291 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
292 Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals. J Biol Inorg Chem. 2014 Jan;19(1):17-27. doi: 10.1007/s00775-013-1051-z. Epub 2013 Oct 17.
293 The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription. Chem Biol Interact. 2014 Aug 5;219:123-32. doi: 10.1016/j.cbi.2014.05.019. Epub 2014 Jun 4.
294 Elevated GSH level increases cadmium resistance through down-regulation of Sp1-dependent expression of the cadmium transporter ZIP8. Mol Pharmacol. 2008 Sep;74(3):823-33. doi: 10.1124/mol.108.046862. Epub 2008 Jun 12.
295 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
296 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
297 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
298 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
299 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
300 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
301 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
302 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
303 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
304 Oxidative Stress-Protective and Anti-Melanogenic Effects of Loliolide and Ethanol Extract from Fresh Water Green Algae, Prasiola japonica. Int J Mol Sci. 2018 Sep 18;19(9):2825. doi: 10.3390/ijms19092825.
305 Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
306 Impaired migration of trophoblast cells caused by simvastatin is associated with decreased membrane IGF-I receptor, MMP2 activity and HSP27 expression. Hum Reprod. 2007 Apr;22(4):1161-7. doi: 10.1093/humrep/del464. Epub 2006 Dec 11.
307 Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway. Pharmacogn Mag. 2016 May;12(Suppl 2):S237-44. doi: 10.4103/0973-1296.182154. Epub 2016 May 11.
308 Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. J Nutr Biochem. 2008 Sep;19(9):594-603. doi: 10.1016/j.jnutbio.2007.08.003. Epub 2007 Dec 21.
309 Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation. Mol Cell Endocrinol. 2012 Jan 2;348(1):260-9. doi: 10.1016/j.mce.2011.09.002. Epub 2011 Sep 6.
310 Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem. 2005 Aug 1;95(5):955-69. doi: 10.1002/jcb.20452.
311 Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Pharmacology. 2009;83(1):18-25. doi: 10.1159/000166183. Epub 2008 Oct 30.
312 Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4098-112. doi: 10.1167/iovs.05-1230.
313 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
314 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
315 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
316 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
317 Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412-22. doi: 10.1016/j.cbi.2013.03.011. Epub 2013 Mar 22.
318 Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. J Investig Med. 2001 Jan;49(1):68-76. doi: 10.2310/6650.2001.34092.
319 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
320 The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338-47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7.
321 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
322 Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73:105138. doi: 10.1016/j.tiv.2021.105138. Epub 2021 Mar 6.
323 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
324 Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288-95. doi: 10.1111/j.1365-2249.2007.03335.x. Epub 2007 Feb 7.
325 Adipogenic Effects and Gene Expression Profiling of Firemaster? 550 Components in Human Primary Preadipocytes. Environ Health Perspect. 2017 Sep 14;125(9):097013. doi: 10.1289/EHP1318.
326 Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 2006 Nov 21;7:27. doi: 10.1186/1471-2172-7-27.
327 Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC). Front Microbiol. 2015 Dec 22;6:1452. doi: 10.3389/fmicb.2015.01452. eCollection 2015.
328 Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res. 2005 Sep 1;11(17):6325-32. doi: 10.1158/1078-0432.CCR-05-0182.
329 Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. Br J Cancer. 2010 Jun 29;103(1):52-60.
330 Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis. Blood. 2005 May 15;105(10):3833-40. doi: 10.1182/blood-2004-03-0828. Epub 2004 Aug 3.
331 Monomeric and oligomeric flavanols maintain the endogenous glucocorticoid response in human macrophages in pro-oxidant conditions in vitro. Chem Biol Interact. 2018 Aug 1;291:237-244.
332 Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1 or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling. Arch Oral Biol. 2012 May;57(5):483-90. doi: 10.1016/j.archoralbio.2011.10.007. Epub 2011 Nov 25.
333 Ca(2+) Signaling and IL-8 Secretion in Human Testicular Peritubular Cells Involve the Cation Channel TRPV2. Int J Mol Sci. 2018 Sep 19;19(9):2829. doi: 10.3390/ijms19092829.
334 Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am J Respir Crit Care Med. 2000 Jan;161(1):249-56. doi: 10.1164/ajrccm.161.1.9804096.
335 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
336 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
337 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther. 2003 Jun;305(3):932-42. doi: 10.1124/jpet.103.049098. Epub 2003 Mar 20.
338 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
339 Hypomethylation mediated by decreased DNMTs involves in the activation of proto-oncogene MPL in TK6 cells treated with hydroquinone. Toxicol Lett. 2012 Mar 25;209(3):239-45. doi: 10.1016/j.toxlet.2011.12.020. Epub 2012 Jan 8.
340 4.8% sevoflurane induces activation of autophagy in human neuroblastoma SH-SY5Y cells by the AMPK/mTOR signaling pathway. Neurotoxicology. 2022 May;90:256-264. doi: 10.1016/j.neuro.2022.04.008. Epub 2022 Apr 23.
341 Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor. J Biochem Mol Toxicol. 2023 Jun;37(6):e23348. doi: 10.1002/jbt.23348. Epub 2023 Mar 31.
342 Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci. 2007 Jan;1095:35-44. doi: 10.1196/annals.1397.005.
343 Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol. 2004 Oct 19;502(3):169-83. doi: 10.1016/j.ejphar.2004.09.006.
344 Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling. Toxicol In Vitro. 2018 Oct;52:306-313. doi: 10.1016/j.tiv.2018.07.001. Epub 2018 Jul 9.
345 Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis. 2006 Sep;11(9):1545-59. doi: 10.1007/s10495-006-8764-1.
346 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
347 Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1. Eur Rev Med Pharmacol Sci. 2016;20(6):1203-13.
348 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
349 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
350 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
351 Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity. Chem Res Toxicol. 2019 Apr 15;32(4):589-602. doi: 10.1021/acs.chemrestox.8b00286. Epub 2019 Mar 15.
352 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
353 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
354 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
355 Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
356 Nitric oxide causes anoikis through attenuation of E-cadherin and activation of caspase-3 in human gastric carcinoma AZ-521 cells infected with Mycoplasma hyorhinis. J Vet Med Sci. 2010 Jul;72(7):869-74.
357 Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci. 1999 Aug;112 ( Pt 16):2657-66. doi: 10.1242/jcs.112.16.2657.
358 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
359 Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9. doi: 10.1016/j.bbrc.2009.01.134. Epub 2009 Jan 27.
360 Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One. 2012;7(4):e36110.
361 Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicol Lett. 2021 Mar 1;338:1-9. doi: 10.1016/j.toxlet.2020.11.011. Epub 2020 Nov 25.
362 Cannabidiol selectively modulates interleukin (IL)-1 and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021 Dec;464:153016. doi: 10.1016/j.tox.2021.153016. Epub 2021 Nov 2.
363 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
364 Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. J Biol Chem. 2016 Feb 12;291(7):3639-47. doi: 10.1074/jbc.M115.679704. Epub 2015 Dec 18.
365 Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1194-9. doi: 10.1161/01.atv.0000022694.16328.cc.
366 Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011 Sep 1;255(2):138-49.
367 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
368 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
369 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
370 Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. J Biol Chem. 2002 Oct 11;277(41):38212-21. doi: 10.1074/jbc.M205142200. Epub 2002 Jul 29.
371 The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology. 2006 Jan 20;218(1):30-8. doi: 10.1016/j.tox.2005.09.014. Epub 2005 Nov 16.
372 Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer. 2015 May 14;14:103. doi: 10.1186/s12943-015-0367-4.
373 Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res Mol Brain Res. 2001 Feb 19;87(1):100-8. doi: 10.1016/s0165-3806(00)00154-1.
374 Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines. Antiviral Res. 2011 Aug;91(2):112-9. doi: 10.1016/j.antiviral.2011.04.018. Epub 2011 May 17.
375 The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts. Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:44-9. doi: 10.1046/j.1365-2036.2000.014s1044.x.
376 Regulation of keratinocyte growth factor and scatter factor in cyclosporin-induced gingival overgrowth. J Oral Pathol Med. 2004 Aug;33(7):391-7. doi: 10.1111/j.1600-0714.2004.00223.x.
377 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
378 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
379 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
380 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
381 Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment. Pharmaceutics. 2021 Sep 7;13(9):1415. doi: 10.3390/pharmaceutics13091415.
382 Pentosan polysulfate decreases proliferation and extracellular matrix deposition by vascular smooth muscle cells isolated from failed hemodialysis access grafts. Clin Nephrol. 2000 Aug;54(2):121-7.
383 Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide. PLoS One. 2014 Jun 23;9(6):e99993. doi: 10.1371/journal.pone.0099993. eCollection 2014.
384 Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells. J Pharmacol Sci. 2004 Apr;94(4):403-9. doi: 10.1254/jphs.94.403.
385 Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry. 2005 Jun;162(6):1165-70. doi: 10.1176/appi.ajp.162.6.1165.
386 Low dosage of arsenic trioxide (As(2)O(3)) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis. J Biol Inorg Chem. 2018 Aug;23(6):939-947. doi: 10.1007/s00775-018-1595-z. Epub 2018 Jul 16.
387 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
388 RhoA/MLC signaling pathway is involved in ?-tetrahydrocannabinol-impaired placental angiogenesis. Toxicol Lett. 2018 Mar 15;285:148-155. doi: 10.1016/j.toxlet.2017.12.031. Epub 2018 Jan 4.
389 Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Eur J Pharmacol. 2004 Sep 24;499(3):315-24. doi: 10.1016/j.ejphar.2004.07.114.
390 Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy. Biol Reprod. 2011 Jun;84(6):1148-53. doi: 10.1095/biolreprod.110.088351. Epub 2011 Feb 23.
391 Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. Endocr Relat Cancer. 2010 Feb 18;17(1):169-77. doi: 10.1677/ERC-09-0170. Print 2010 Mar.
392 Effects of niacin on cell adhesion and early atherogenesis: biochemical and functional findings in endothelial cells. Basic Clin Pharmacol Toxicol. 2009 Mar;104(3):206-10. doi: 10.1111/j.1742-7843.2008.00364.x. Epub 2009 Jan 21.
393 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
394 Selenium is critical for cancer-signaling gene expression but not cell proliferation in human colon Caco-2 cells. Biofactors. 2007;31(3-4):155-64. doi: 10.1002/biof.5520310302.
395 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
396 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther. 2008 Oct;7(10):1607-18.
397 Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep. 2016 Sep;36(3):1233-42. doi: 10.3892/or.2016.4944. Epub 2016 Jul 15.
398 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
399 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
400 Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
401 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
402 Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium. Metallomics. 2020 Sep 23;12(9):1400-1415. doi: 10.1039/d0mt00071j.
403 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
404 Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro. Toxicology. 2023 Mar 15;487:153461. doi: 10.1016/j.tox.2023.153461. Epub 2023 Feb 16.
405 Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2. Biochem Biophys Res Commun. 2019 Jun 11;513(4):834-840. doi: 10.1016/j.bbrc.2019.04.081. Epub 2019 Apr 16.
406 ?9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer. Oncol Lett. 2018 Jun;15(6):8527-8535. doi: 10.3892/ol.2018.8407. Epub 2018 Apr 2.
407 Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways. Toxicol In Vitro. 2017 Apr;40:324-335. doi: 10.1016/j.tiv.2017.01.019. Epub 2017 Feb 2.
408 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
409 Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways. Int J Mol Sci. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039.
410 Iron-mediated H2O2 production as a mechanism for cell type-specific inhibition of tumor necrosis factor alpha-induced but not interleukin-1beta-induced IkappaB kinase complex/nuclear factor-kappaB activation. J Biol Chem. 2005 Jan 28;280(4):2912-23. doi: 10.1074/jbc.M409524200. Epub 2004 Nov 17.
411 Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer Res. 2005 Sep 15;65(18):8193-9. doi: 10.1158/0008-5472.CAN-05-1177.
412 Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem Biol Interact. 2010 Jul 30;186(2):127-34. doi: 10.1016/j.cbi.2010.04.027. Epub 2010 May 21.
413 Hydroquinone Exposure Worsens Rheumatoid Arthritis through the Activation of the Aryl Hydrocarbon Receptor and Interleukin-17 Pathways. Antioxidants (Basel). 2021 Jun 7;10(6):929. doi: 10.3390/antiox10060929.
414 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
415 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
416 Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture. Toxicology. 2009 Mar 4;257(1-2):10-6. doi: 10.1016/j.tox.2008.12.002. Epub 2008 Dec 9.
417 Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cells. Biochem Biophys Res Commun. 1993 Feb 26;191(1):149-56. doi: 10.1006/bbrc.1993.1196.
418 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
419 Ethanol and acetone stimulate the proliferation of HaCaT keratinocytes: the possible role of alcohol in exacerbating psoriasis. Arch Dermatol Res. 2003 Jun;295(2):56-62. doi: 10.1007/s00403-003-0399-2. Epub 2003 Apr 26.
420 Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J Hepatol. 1999 Mar;30(3):376-82. doi: 10.1016/s0168-8278(99)80093-2.
421 Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009 Feb 27;256(3):183-90. doi: 10.1016/j.tox.2008.11.016. Epub 2008 Nov 28.
422 Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance. Clin Exp Immunol. 2010 Aug;161(2):298-305. doi: 10.1111/j.1365-2249.2010.04170.x. Epub 2010 May 18.
423 Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol (1985). 2007 Nov;103(5):1728-35. doi: 10.1152/japplphysiol.00707.2007. Epub 2007 Aug 23.
424 The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines. Int J Clin Pharmacol Ther. 2009 Nov;47(11):686-94. doi: 10.5414/cpp47686.
425 Zinc induces chemokine and inflammatory cytokine release from human promonocytes. J Hazard Mater. 2011 Nov 30;196:335-41. doi: 10.1016/j.jhazmat.2011.09.035. Epub 2011 Sep 19.
426 Characterization of drug-specific signaling between primary human hepatocytes and immune cells. Toxicol Sci. 2017 Jul 1;158(1):76-89.
427 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
428 Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia. Leukemia. 2003 Dec;17(12):2418-25. doi: 10.1038/sj.leu.2403152.
429 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
430 Febuxostat Increases Ventricular Arrhythmogenesis Through Calcium Handling Dysregulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci. 2022 Sep 24;189(2):216-224. doi: 10.1093/toxsci/kfac073.
431 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
432 All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J. 2007 Jan;274(2):498-511. doi: 10.1111/j.1742-4658.2006.05597.x.
433 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
434 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
435 The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene. 2001 Feb 1;20(5):645-53. doi: 10.1038/sj.onc.1204123.
436 Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines. Breast. 2018 Oct;41:34-41. doi: 10.1016/j.breast.2018.06.009. Epub 2018 Jun 22.
437 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
438 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
439 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
440 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
441 Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85.
442 All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology. 2006 Mar;147(3):1264-70. doi: 10.1210/en.2005-0854. Epub 2005 Dec 1.
443 Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide. Biochem Pharmacol. 1998 May 1;55(9):1523-9. doi: 10.1016/s0006-2952(97)00677-1.
444 Effects of combined 17beta-estradiol with TCDD on secretion of chemokine IL-8 and expression of its receptor CXCR1 in endometriotic focus-associated cells in co-culture. Hum Reprod. 2006 Apr;21(4):870-9. doi: 10.1093/humrep/dei414. Epub 2006 Mar 3.
445 Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain. Environ Pollut. 2018 Apr;235:948-955. doi: 10.1016/j.envpol.2018.01.008. Epub 2018 Feb 21.
446 Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer. 2002 Sep 15;95(6):1206-14. doi: 10.1002/cncr.10812.
447 Short-term exposure to oleandrin enhances responses to IL-8 by increasing cell surface IL-8 receptors. Br J Pharmacol. 2014 Jul;171(14):3339-51. doi: 10.1111/bph.12493.
448 Preliminary discovery of novel markers for human cell line activation test (h-CLAT). Toxicol In Vitro. 2021 Aug;74:105154. doi: 10.1016/j.tiv.2021.105154. Epub 2021 Mar 25.
449 Expression of neutrophil SOD2 is reduced after lipopolysaccharide stimulation: a potential cause of neutrophil dysfunction in chronic kidney disease. Nephrol Dial Transplant. 2011 Jul;26(7):2195-201. doi: 10.1093/ndt/gfq673. Epub 2010 Nov 2.
450 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
451 CXCR2 Expression on neutrophils is upregulated during the relapsing phase of ocular Behcet disease. Curr Eye Res. 2005 Mar;30(3):195-203. doi: 10.1080/02713680490904331.
452 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
453 Reciprocal regulation of 17beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer. Cytokine. 2009 Jun;46(3):382-91. doi: 10.1016/j.cyto.2009.03.013. Epub 2009 Apr 28.
454 Effects of tobacco compounds on gene expression in fetal lung fibroblasts. Environ Toxicol. 2008 Aug;23(4):423-34.
455 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
456 Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer. Clin Cancer Res. 2012 Jun 15;18(12):3366-76.
457 Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002.
458 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
459 Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem. 2006 Dec;387(12):1629-33. doi: 10.1515/BC.2006.203.
460 Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 2000 Feb;45(3):788-94. doi: 10.1016/s0008-6363(99)00369-7.
461 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
462 Regulatory role of KEAP1 and NRF2 in PPAR expression and chemoresistance in human non-small-cell lung carcinoma cells. Free Radic Biol Med. 2012 Aug 15;53(4):758-68. doi: 10.1016/j.freeradbiomed.2012.05.041. Epub 2012 Jun 7.
463 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
464 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
465 Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther. 2009 May;8(5):1197-206.
466 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
467 Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3767-77.
468 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
469 hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation. Front Mol Neurosci. 2020 Jul 6;13:119. doi: 10.3389/fnmol.2020.00119. eCollection 2020.
470 Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet. 2012 Sep 15;21(18):4104-14. doi: 10.1093/hmg/dds239. Epub 2012 Jun 20.
471 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
472 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
473 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
474 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
475 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
476 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
477 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
478 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
479 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
480 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
481 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
482 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
483 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
484 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
485 Complex genetic response of human cells to sublethal levels of pure nitric oxide. Cancer Res. 1998 Aug 1;58(15):3435-40.
486 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
487 Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells. Oncogene. 2016 Aug 25;35(34):4518-28. doi: 10.1038/onc.2015.511. Epub 2016 Feb 8.
488 Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer. 2010 Aug 20;9:220.
489 Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway. J Biochem Mol Toxicol. 2023 Jun;37(6):e23328. doi: 10.1002/jbt.23328. Epub 2023 Feb 19.
490 Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci. 2009 Aug;110(2):376-88. doi: 10.1093/toxsci/kfp101. Epub 2009 May 18.
491 Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. 2015 Mar;35(3):1063-76. doi: 10.1111/liv.12626. Epub 2014 Jul 30.
492 Docosahexaenoic acid regulates gene expression in HUVEC cells treated with polycyclic aromatic hydrocarbons. Toxicol Lett. 2015 Jul 16;236(2):75-81.
493 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
494 Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation. Br J Nutr. 2006 Nov;96(5):811-9.
495 COX-2 and PPAR-gama confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013 Jan;12(1):69-82.
496 Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 1996 Sep;21(9):995-1004.
497 Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol. 2007 Dec;17(12):774-80.
498 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res. 2006 Feb 15;66(4):2067-73.
499 A2E selectively induces cox-2 in ARPE-19 and human neural cells. Curr Eye Res. 2006 Mar;31(3):259-63.
500 Induction of CCAAT/enhancer-binding protein-homologous protein by cigarette smoke through the superoxide anion-triggered PERK-eIF2 pathway. Toxicology. 2011 Sep 5;287(1-3):105-12. doi: 10.1016/j.tox.2011.06.005. Epub 2011 Jun 15.
501 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
502 High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities. Arch Toxicol. 2017 Mar;91(3):1367-1383. doi: 10.1007/s00204-016-1781-0. Epub 2016 Jun 29.
503 Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Toxicol Sci. 2014 Jan;137(1):234-48. doi: 10.1093/toxsci/kft232. Epub 2013 Oct 17.
504 Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma. 2004 Nov;57(5):1032-7. doi: 10.1097/01.ta.0000114087.46566.eb.
505 Glucosamine promotes osteogenic differentiation of dental pulp stem cells through modulating the level of the transforming growth factor-beta type I receptor. J Cell Physiol. 2010 Oct;225(1):140-51.
506 Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype. Mol Med. 2006 Sep-Oct;12(9-10):237-45. doi: 10.2119/2006C00026.Baroni.
507 Chronic senescent human mesenchymal stem cells as possible contributor to the wound healing disorder after exposure to the alkylating agent sulfur mustard. Arch Toxicol. 2021 Feb;95(2):727-747. doi: 10.1007/s00204-020-02946-5. Epub 2021 Jan 25.
508 Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun. 2009 Sep 18;387(2):342-7. doi: 10.1016/j.bbrc.2009.07.022. Epub 2009 Jul 10.
509 Diesel exhaust particulate-induced activation of Stat3 requires activities of EGFR and Src in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L422-9. doi: 10.1152/ajplung.00204.2006. Epub 2006 Oct 6.
510 Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathway. Toxicol Appl Pharmacol. 2020 Dec 1;408:115273. doi: 10.1016/j.taap.2020.115273. Epub 2020 Oct 6.
511 Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma. Neoplasia. 2007 Mar;9(3):192-9. doi: 10.1593/neo.06781.
512 Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. Biocell. 2009 Aug;33(2):107-14.
513 Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma. BMC Cancer. 2011 Jun 16;11:255. doi: 10.1186/1471-2407-11-255.
514 Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014 Feb 1;87(3):424-34. doi: 10.1016/j.bcp.2013.11.008. Epub 2013 Nov 23.
515 Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology. 2009 Jun;34(7):1819-28. doi: 10.1038/npp.2009.4. Epub 2009 Mar 18.
516 Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis. J Cell Biochem. 2017 Apr;118(4):819-828. doi: 10.1002/jcb.25757. Epub 2016 Nov 28.
517 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
518 Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. J Neurochem. 2005 Dec;95(6):1785-93. doi: 10.1111/j.1471-4159.2005.03517.x.
519 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
520 Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009 Oct;53(9):1192-9. doi: 10.1111/j.1399-6576.2009.02036.x. Epub 2009 Jun 30.
521 [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
522 Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPAR-dependent pathway. Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.
523 Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 2004 Oct 8;214(1):103-13. doi: 10.1016/j.canlet.2004.03.047.
524 Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol. 2000 Mar;108(3):574-81. doi: 10.1046/j.1365-2141.2000.01852.x.
525 Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.
526 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol. 2000 Jan;182(1):24-32. doi: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6.
527 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004 Nov;385(11):1099-103. doi: 10.1515/BC.2004.143.
528 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
529 Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol. 2009 Oct;46(16):3345-57. doi: 10.1016/j.molimm.2009.07.019. Epub 2009 Sep 3.
530 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
531 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
532 Identification of cornifelin and early growth response-1 gene as novel biomarkers for in vitro eye irritation using a 3D reconstructed human cornea model MCTT HCE?. Arch Toxicol. 2015 Sep;89(9):1589-98. doi: 10.1007/s00204-014-1390-8. Epub 2014 Nov 7.
533 Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis. Gynecol Endocrinol. 2005 Mar;20(3):127-31. doi: 10.1080/09513590400021086.
534 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
535 An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089257. doi: 10.1177/09603271221089257.
536 Mitophagy inhibits proliferation by decreasing cyclooxygenase-2 (COX-2) in arsenic trioxide-treated HepG2 cells. Environ Toxicol Pharmacol. 2016 Jul;45:212-21.
537 The anti-cancer drug gefitinib accelerates Fas-mediated apoptosis by enhancing caspase-8 activation in cancer cells. J Toxicol Sci. 2019;44(6):435-440. doi: 10.2131/jts.44.435.
538 NF-B potentiates caspase independent hydrogen peroxide induced cell death. PLoS One. 2011 Feb 15;6(2):e16815. doi: 10.1371/journal.pone.0016815.
539 Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583-91. doi: 10.3892/or.2010.1097. Epub 2010 Dec 10.
540 Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1071-7. doi: 10.1097/01.meg.0000231750.68513.6c.
541 Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine. Toxicol In Vitro. 2016 Sep;35:66-76. doi: 10.1016/j.tiv.2016.05.013. Epub 2016 May 26.
542 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
543 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
544 Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem. 2003 May 16;278(20):18092-100. doi: 10.1074/jbc.M300265200. Epub 2003 Mar 13.
545 TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells. J Pathol. 2011 Feb;223(3):378-89. doi: 10.1002/path.2797. Epub 2010 Oct 29.
546 Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res. 2005 Sep 1;65(17):7856-65. doi: 10.1158/0008-5472.CAN-05-1056.
547 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
548 Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells initro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology. 2017 Jun;152(8):2022-2036.
549 AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell. 2009 Nov 6;16(5):401-12. doi: 10.1016/j.ccr.2009.09.028.
550 Linking site-specific loss of histone acetylation to repression of gene expression by the mycotoxin ochratoxin A. Arch Toxicol. 2018 Feb;92(2):995-1014.
551 Dolutegravir Impairs Stem Cell-Based 3D Morphogenesis Models in a Manner Dependent on Dose and Timing of Exposure: An Implication for Its Developmental Toxicity. Toxicol Sci. 2021 Nov 24;184(2):191-203. doi: 10.1093/toxsci/kfab112.
552 Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology. 2003 Sep;144(9):3852-9. doi: 10.1210/en.2003-0098.
553 Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion kinase and Akt. J Biol Chem. 2002 Jul 26;277(30):27393-400. doi: 10.1074/jbc.M201963200. Epub 2002 May 14.
554 Effects of gonadotrophin-releasing hormone agonists on apoptosis of granulosa cells. Ann N Y Acad Sci. 2005 May;1042:531-7. doi: 10.1196/annals.1338.065.
555 The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp Eye Res. 2010 Jul;91(1):15-25.
556 Inhibiting AKT signaling pathway with cilostazol and meloxicam synergism for suppressing K562 cells in vitro. J Biochem Mol Toxicol. 2022 Nov;36(11):e23185. doi: 10.1002/jbt.23185. Epub 2022 Aug 3.
557 Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer. 2002 Feb 1;86(3):443-8. doi: 10.1038/sj.bjc.6600079.
558 Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways. Toxicol In Vitro. 2012 Aug;26(5):649-55. doi: 10.1016/j.tiv.2012.01.024. Epub 2012 Feb 8.
559 Dose- and time-dependent transcriptional response of Ishikawa cells exposed to genistein. Toxicol Sci. 2016 May;151(1):71-87.
560 Evaluation of developmental toxicity using undifferentiated human embryonic stem cells. J Appl Toxicol. 2015 Feb;35(2):205-18.
561 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
562 Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals. Toxicology. 2013 Jan 7;303:17-24.
563 Redox/methylation mediated abnormal DNA methylation as regulators of ambient fine particulate matter-induced neurodevelopment related impairment in human neuronal cells. Sci Rep. 2016 Sep 14;6:33402. doi: 10.1038/srep33402.
564 Evaluation of mRNA markers in differentiating human SH-SY5Y cells for estimation of developmental neurotoxicity. Neurotoxicology. 2023 Jul;97:65-77. doi: 10.1016/j.neuro.2023.05.011. Epub 2023 May 18.
565 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
566 Astaxanthin protects mesenchymal stem cells from oxidative stress by direct scavenging of free radicals and modulation of cell signaling. Chem Biol Interact. 2021 Jan 5;333:109324. doi: 10.1016/j.cbi.2020.109324. Epub 2020 Nov 17.
567 Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr. 2012 Mar;107(6):781-90. doi: 10.1017/S0007114511003631. Epub 2011 Aug 1.
568 Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. Int J Mol Sci. 2023 Mar 15;24(6):5604. doi: 10.3390/ijms24065604.
569 Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway. Cancer Cell Int. 2013 Mar 13;13(1):25. doi: 10.1186/1475-2867-13-25.
570 Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Mol Endocrinol. 2010 May;24(5):969-80. doi: 10.1210/me.2009-0148. Epub 2010 Mar 8.
571 K-RAS transformation in prostate epithelial cell overcomes H2O2-induced apoptosis via upregulation of gamma-glutamyltransferase-2. Toxicol In Vitro. 2012 Apr;26(3):429-34. doi: 10.1016/j.tiv.2012.01.013. Epub 2012 Jan 17.
572 Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem Biophys Res Commun. 1999 Apr 29;258(1):215-21. doi: 10.1006/bbrc.1999.0491.
573 Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor co-activator-1 protein. Br J Pharmacol. 2010 Oct;161(4):771-81. doi: 10.1111/j.1476-5381.2010.00900.x.
574 Under ambient UVA exposure, pefloxacin exhibits both immunomodulatory and genotoxic effects via multiple mechanisms. J Photochem Photobiol B. 2018 Jan;178:593-605. doi: 10.1016/j.jphotobiol.2017.12.014. Epub 2017 Dec 15.
575 Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2020 Sep 27;12(10):2774. doi: 10.3390/cancers12102774.
576 Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis. 2011 May;32(5):686-94. doi: 10.1093/carcin/bgr025. Epub 2011 Feb 10.
577 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
578 Malathion induced cancer-linked gene expression in human lymphocytes. Environ Res. 2020 Mar;182:109131. doi: 10.1016/j.envres.2020.109131. Epub 2020 Jan 10.
579 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
580 Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome. Sci Rep. 2014 Dec 4;4:7310. doi: 10.1038/srep07310.
581 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
582 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
583 Non-canonical Opioid Signaling Inhibits Itch Transmission in the Spinal Cord of Mice. Cell Rep. 2018 Apr 17;23(3):866-877. doi: 10.1016/j.celrep.2018.03.087.
584 Protein kinase Cdelta-dependent induction of manganese superoxide dismutase gene expression by microtubule-active anticancer drugs. J Biol Chem. 1998 Dec 18;273(51):34639-45. doi: 10.1074/jbc.273.51.34639.
585 Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia. 2000 Nov-Dec;2(6):505-13. doi: 10.1038/sj.neo.7900120.
586 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
587 Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis. 2011 May;32(5):723-31. doi: 10.1093/carcin/bgr038. Epub 2011 Feb 28.
588 Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol. 2005 May;67(5):1808-17. doi: 10.1124/mol.104.005769. Epub 2005 Feb 9.
589 Role of BAX in the apoptotic response to anticancer agents. Science. 2000 Nov 3;290(5493):989-92. doi: 10.1126/science.290.5493.989.
590 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290.
591 The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study. Toxicol In Vitro. 2020 Aug;66:104884. doi: 10.1016/j.tiv.2020.104884. Epub 2020 May 8.
592 Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br J Cancer. 2011 Jul 12;105(2):221-30. doi: 10.1038/bjc.2011.229.
593 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
594 Anti-cancer properties of glucosamine-hydrochloride in YD-8 human oral cancer cells: Induction of the caspase-dependent apoptosis and down-regulation of HIF-1. Toxicol In Vitro. 2012 Feb;26(1):42-50. doi: 10.1016/j.tiv.2011.10.005. Epub 2011 Oct 13.
595 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
596 THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell-Derived Neurons. Mol Neuropsychiatry. 2017 Nov;3(2):73-84. doi: 10.1159/000477762. Epub 2017 Jul 20.
597 Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J. 2014 Feb;14(1):35-40. doi: 10.1038/tpj.2013.3. Epub 2013 Feb 12.
598 Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.
599 Transcriptomics and methylomics of CD4-positive T cells in arsenic-exposed women. Arch Toxicol. 2017 May;91(5):2067-2078. doi: 10.1007/s00204-016-1879-4. Epub 2016 Nov 12.
600 Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis. 2005 May;26(5):883-91. doi: 10.1093/carcin/bgi036. Epub 2005 Feb 10.
601 Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. Br J Cancer. 2011 Apr 12;104(8):1278-87. doi: 10.1038/bjc.2011.84.
602 Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Mol Cancer. 2011 Jul 31;10:95. doi: 10.1186/1476-4598-10-95.
603 Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol Cell Biochem. 2011 Jul;353(1-2):167-76. doi: 10.1007/s11010-011-0783-8. Epub 2011 Mar 23.
604 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
605 Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int J Cancer. 2000 Dec 15;88(6):873-80. doi: 10.1002/1097-0215(20001215)88:6<873::aid-ijc6>3.0.co;2-b.
606 Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. Toxicol In Vitro. 2009 Apr;23(3):486-99.
607 Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro. J Appl Toxicol. 2015 Jul;35(7):831-41.
608 Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway. Environ Toxicol. 2023 Jul;38(7):1473-1483. doi: 10.1002/tox.23777. Epub 2023 Apr 23.
609 Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38. Chem Biol Interact. 2012 Jan 25;195(2):154-64.
610 Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine. Cancer Sci. 2003 Oct;94(10):886-93.
611 Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIM(EL) to attenuate apoptosis in BEAS-2B cells. Chem Biol Interact. 2023 Jan 5;369:110304. doi: 10.1016/j.cbi.2022.110304. Epub 2022 Dec 10.
612 Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. Mol Pharmacol. 2004 Feb;65(2):470-8.
613 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
614 Early Transcriptomic Changes upon Thalidomide Exposure Influence the Later Neuronal Development in Human Embryonic Stem Cell-Derived Spheres. Int J Mol Sci. 2020 Aug 3;21(15):5564. doi: 10.3390/ijms21155564.
615 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
616 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
617 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
618 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
619 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
620 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
621 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
622 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
623 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
624 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
625 Molecular characterization of a toxicological tipping point during human stem cell differentiation. Reprod Toxicol. 2020 Jan;91:1-13. doi: 10.1016/j.reprotox.2019.10.001. Epub 2019 Oct 7.
626 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
627 Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):140-50.
628 Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following exposure to di(2-ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes. Environ Toxicol. 2019 Apr;34(4):401-414.
629 A high-throughput screen for teratogens using human pluripotent stem cells. Toxicol Sci. 2014 Jan;137(1):76-90. doi: 10.1093/toxsci/kft239. Epub 2013 Oct 23.
630 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
631 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
632 Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res. 2006 Dec;56(4):450-8. doi: 10.1016/j.neures.2006.09.006. Epub 2006 Oct 17.
633 Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor alpha signalling and results in tamoxifen insensitive proliferation. BMC Cancer. 2014 Apr 23;14:283.
634 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
635 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
636 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
637 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
638 Oxidative stress modulates expression of immune checkpoint genes via activation of AhR signaling. Toxicol Appl Pharmacol. 2022 Dec 15;457:116314. doi: 10.1016/j.taap.2022.116314. Epub 2022 Nov 9.
639 Essential role of HDAC6 in the regulation of PD-L1 in?melanoma. Mol Oncol. 2016 May;10(5):735-750. doi: 10.1016/j.molonc.2015.12.012. Epub 2016 Jan 6.
640 CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol Toxicol. 2022 Oct;38(5):825-845. doi: 10.1007/s10565-021-09613-0. Epub 2021 May 20.
641 An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. Toxicol In Vitro. 2017 Apr;40:11-25. doi: 10.1016/j.tiv.2016.12.005. Epub 2016 Dec 10.
642 Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife. 2018 Aug 1;7:e38430. doi: 10.7554/eLife.38430.
643 Novel approach for detecting global epigenetic alterations associated with tumor cell aneuploidy. Int J Cancer. 2007 Oct 1;121(7):1487-93. doi: 10.1002/ijc.22847.
644 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
645 [Effects of As2O3 on tissue factor, plasminogen activator inhibitor-1 and -2 expression in NB4, HL-60 and THP-1 cells]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Oct;34(4):645-9.
646 Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42. doi: 10.1073/pnas.1007863107. Epub 2010 Nov 22.
647 Imiquimod: a potential weapon against Dupuytren contracture. Med Hypotheses. 2006;66(5):991-2. doi: 10.1016/j.mehy.2005.09.052. Epub 2005 Dec 20.
648 Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells. PLoS One. 2016 Jan 22;11(1):e0147312. doi: 10.1371/journal.pone.0147312. eCollection 2016.
649 The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma. Biomaterials. 2010 Jul;31(20):5325-35. doi: 10.1016/j.biomaterials.2010.03.037. Epub 2010 Apr 9.
650 Proliferation of cultured human gingival fibroblasts caused by isradipine, a dihydropyridine-derivative calcium antagonist. Eur J Med Res. 2004 Jun 30;9(6):313-5.
651 The effect of valdecoxib on the production of growth factors evoked by hypoxia and bacterial lipopolysaccharide in HMEC-1 cells. Adv Clin Exp Med. 2013 Nov-Dec;22(6):795-800.
652 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
653 Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol. 2004 May;30(5):662-70. doi: 10.1165/rcmb.2003-0267OC. Epub 2003 Nov 20.
654 Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thromb Haemost. 1996 Nov;76(5):729-34.
655 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
656 Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages. Arthritis Rheum. 2008 Dec;58(12):3675-83.
657 Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples. Clin Cancer Res. 2009 May 1;15(9):3076-83. doi: 10.1158/1078-0432.CCR-08-3004. Epub 2009 Apr 21.
658 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
659 Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Metabolism. 2003 May;52(5):652-7. doi: 10.1053/meta.2003.50100.
660 Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist. Biochem Pharmacol. 2010 May 1;79(9):1310-6. doi: 10.1016/j.bcp.2009.12.018. Epub 2010 Jan 8.
661 Repression of hepatocyte nuclear factor 4 alpha by AP-1 underlies dyslipidemia associated with retinoic acid. J Lipid Res. 2019 Apr;60(4):794-804. doi: 10.1194/jlr.M088880. Epub 2019 Feb 1.
662 Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. Biochem Biophys Res Commun. 2005 Jun 17;331(4):1533-41. doi: 10.1016/j.bbrc.2005.04.071.
663 Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro. Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1228-36. doi: 10.1161/ATVBAHA.110.205500. Epub 2010 Mar 25.
664 BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011 Sep 16;146(6):904-17.
665 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
666 Functional characterization of peroxisome proliferator-activated receptor-/ expression in colon cancer. Mol Carcinog. 2011 Nov;50(11):884-900. doi: 10.1002/mc.20757. Epub 2011 Mar 11.
667 Aspirin-induced apoptosis in jurkat cells is not mediated by peroxisome proliferator-activated receptor delta. Mol Cell Biochem. 2004 Nov;266(1-2):57-63. doi: 10.1023/b:mcbi.0000049138.67699.7b.
668 (9)-Tetrahydrocannabinol upregulates fatty acid 2-hydroxylase (FA2H) via PPAR induction: A possible evidence for the cancellation of PPAR/-mediated inhibition of PPAR in MDA-MB-231?cells. Arch Biochem Biophys. 2019 Feb 15;662:219-225. doi: 10.1016/j.abb.2018.12.011. Epub 2018 Dec 13.
669 Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Anticancer Res. 2009 Sep;29(9):3647-58.
670 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
671 Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull. 2003 Apr;26(4):510-7.
672 Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 2007 Dec;20(6):875-81.
673 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
674 Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther. 2005 Aug;314(2):626-35. doi: 10.1124/jpet.105.086504. Epub 2005 Apr 21.
675 Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br J Pharmacol. 2010 Nov;161(5):1059-69. doi: 10.1111/j.1476-5381.2010.00946.x.
676 Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother. 2004 Feb;53(2):174-9. doi: 10.1093/jac/dkh056. Epub 2004 Jan 16.
677 Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.
678 The effect of fexofenadine on expression of intercellular adhesion molecule 1 and induction of apoptosis on peripheral eosinophils. Allergy Asthma Proc. 2005 Jul-Aug;26(4):292-8.
679 Antiallergic effects of H1-receptor antagonists. Allergy. 2000;55 Suppl 64:17-27. doi: 10.1034/j.1398-9995.2000.00803.x.
680 Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferon-alpha + ribavirin therapy. Rom J Gastroenterol. 2003 Jun;12(2):91-5.
681 Some non-sensitizers upregulate CD54 expression by activation of the NLRP3 inflammasome in THP-1 cells. J Toxicol Sci. 2019;44(3):213-224. doi: 10.2131/jts.44.213.
682 A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples. Appl Immunohistochem Mol Morphol. 2016 Nov/Dec;24(10):695-702. doi: 10.1097/PAI.0000000000000246.